Karuna Therapeutics
Clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions.
Market cap
$12.6b
Enterprise value
$11.4b
Share price
$329.83 KRTX
Authorizing premium user...